The drug acamprosate can reduce the relapse rate among patients being treated for alcoholism, according to a Cochrane Systematic Review.
Researchers found the drug showed moderate benefits in trials when used in addition to non-drug treatments.
The review looked at data from 24 randomised controlled trials involving 6,915 alcohol dependent patients who were also undergoing psychosocial therapies. It found that the risk of a patient on acamprosate returning to drinking was 86 per cent of that of a patient who took a placebo instead.
Nursing Times Learning
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Click on the topics below to get started: